141 related articles for article (PubMed ID: 12637939)
41. Intratumoral delivery of IL-18 naked DNA induces T-cell activation and Th1 response in a mouse hepatic cancer model.
Chang CY; Lee J; Kim EY; Park HJ; Kwon CH; Joh JW; Kim SJ
BMC Cancer; 2007 May; 7():87. PubMed ID: 17519043
[TBL] [Abstract][Full Text] [Related]
42. Synergistic antitumor effect by coexpression of chemokine CCL21/SLC and costimulatory molecule LIGHT.
Hisada M; Yoshimoto T; Kamiya S; Magami Y; Miyaji H; Yoneto T; Tamada K; Aoki T; Koyanagi Y; Mizuguchi J
Cancer Gene Ther; 2004 Apr; 11(4):280-8. PubMed ID: 15002032
[TBL] [Abstract][Full Text] [Related]
43. Interleukin-4 gene transduced tumor cells promote a potent tumor-specific Th1-type response in cooperation with interferon-alpha transduction.
Eguchi J; Hiroishi K; Ishii S; Baba T; Matsumura T; Hiraide A; Okada H; Imawari M
Gene Ther; 2005 May; 12(9):733-41. PubMed ID: 15772692
[TBL] [Abstract][Full Text] [Related]
44. Antitumor mechanism of intratumoral injection with IL-12-expressing adenoviral vector against IL-12-unresponsive tumor.
Kanagawa N; Gao JQ; Motomura Y; Yanagawa T; Mukai Y; Yoshioka Y; Okada N; Nakagawa S
Biochem Biophys Res Commun; 2008 Aug; 372(4):821-5. PubMed ID: 18519033
[TBL] [Abstract][Full Text] [Related]
45. Gene therapy with CX3CL1/Fractalkine induces antitumor immunity to regress effectively mouse hepatocellular carcinoma.
Tang L; Hu HD; Hu P; Lan YH; Peng ML; Chen M; Ren H
Gene Ther; 2007 Aug; 14(16):1226-34. PubMed ID: 17597794
[TBL] [Abstract][Full Text] [Related]
46. Antitumor effects of interleukin-18 gene-modified hepatocyte cell line on implanted liver carcinoma.
Leng J; Zhang L; Yao H; Cao X
Chin Med J (Engl); 2003 Oct; 116(10):1475-9. PubMed ID: 14570604
[TBL] [Abstract][Full Text] [Related]
47. Intensification of antitumor effect by T helper 1-dominant adoptive immunogene therapy for advanced orthotopic colon cancer.
Nakamori M; Iwahashi M; Nakamura M; Ueda K; Zhang X; Yamaue H
Clin Cancer Res; 2003 Jun; 9(6):2357-65. PubMed ID: 12796406
[TBL] [Abstract][Full Text] [Related]
48. The secreted form of the p40 subunit of interleukin (IL)-12 inhibits IL-23 functions and abrogates IL-23-mediated antitumour effects.
Shimozato O; Ugai S; Chiyo M; Takenobu H; Nagakawa H; Wada A; Kawamura K; Yamamoto H; Tagawa M
Immunology; 2006 Jan; 117(1):22-8. PubMed ID: 16423037
[TBL] [Abstract][Full Text] [Related]
49. Bacteriophages support anti-tumor response initiated by DC-based vaccine against murine transplantable colon carcinoma.
Pajtasz-Piasecka E; Rossowska J; Duś D; Weber-Dabrowska B; Zabłocka A; Górski A
Immunol Lett; 2008 Feb; 116(1):24-32. PubMed ID: 18166233
[TBL] [Abstract][Full Text] [Related]
50. Inactivated Sendai virus particles eradicate tumors by inducing immune responses through blocking regulatory T cells.
Kurooka M; Kaneda Y
Cancer Res; 2007 Jan; 67(1):227-36. PubMed ID: 17210703
[TBL] [Abstract][Full Text] [Related]
51. Antitumor effect of human pancreatic cancer cells transduced with cytokine genes which activate Th1 helper T cells.
Yoshida Y; Tasaki K; Kimurai M; Takenaga K; Yamamoto H; Yamaguchi T; Saisho H; Sakiyama S; Tagawa M
Anticancer Res; 1998; 18(1A):333-5. PubMed ID: 9568099
[TBL] [Abstract][Full Text] [Related]
52. Endogenous IL-21 restricts CD8+ T cell expansion and is not required for tumor immunity.
Søndergaard H; Coquet JM; Uldrich AP; McLaughlin N; Godfrey DI; Sivakumar PV; Skak K; Smyth MJ
J Immunol; 2009 Dec; 183(11):7326-36. PubMed ID: 19915059
[TBL] [Abstract][Full Text] [Related]
53. In vivo antitumor activity of interleukin 21 mediated by natural killer cells.
Wang G; Tschoi M; Spolski R; Lou Y; Ozaki K; Feng C; Kim G; Leonard WJ; Hwu P
Cancer Res; 2003 Dec; 63(24):9016-22. PubMed ID: 14695220
[TBL] [Abstract][Full Text] [Related]
54. Combination of IL-12 and IL-18 of electro-gene therapy synergistically inhibits tumor growth.
Tamura T; Nishi T; Goto T; Takeshima H; Ushio Y; Sakata T
Anticancer Res; 2003; 23(2B):1173-9. PubMed ID: 12820368
[TBL] [Abstract][Full Text] [Related]
55. Murine dendritic cells pulsed with an anti-idiotype antibody induce antigen-specific protective antitumor immunity.
Saha A; Chatterjee SK; Foon KA; Primus FJ; Bhattacharya-Chatterjee M
Cancer Res; 2003 Jun; 63(11):2844-54. PubMed ID: 12782590
[TBL] [Abstract][Full Text] [Related]
56. Interleukin-12-mediated induction of systemic immunity in the periphery and recruitment of activated T cells into the brain produce limited antitumor effects compared with interleukin-2.
Iwadate Y; Namba H; Sakiyama S; Yamaura A; Tagawa M
Int J Mol Med; 2002 Dec; 10(6):741-7. PubMed ID: 12430001
[TBL] [Abstract][Full Text] [Related]
57. A novel dendritic cell-based cancer vaccine produces promising results in a syngenic CC-36 murine colon adenocarcinoma model.
Jack AM; Aydin N; Montenegro G; Alam K; Wallack M
J Surg Res; 2007 May; 139(2):164-9. PubMed ID: 17275030
[TBL] [Abstract][Full Text] [Related]
58. Injection of IL-12 gene-transduced dendritic cells into mouse liver tumor lesions activates both innate and acquired immunity.
Tatsumi T; Takehara T; Yamaguchi S; Sasakawa A; Miyagi T; Jinushi M; Sakamori R; Kohga K; Uemura A; Ohkawa K; Storkus WJ; Hayashi N
Gene Ther; 2007 Jun; 14(11):863-71. PubMed ID: 17344900
[TBL] [Abstract][Full Text] [Related]
59. Mechanisms of experimental cancer cachexia. Interaction between mononuclear phagocytes and colon-26 carcinoma and its relevance to IL-6-mediated cancer cachexia.
Strassmann G; Jacob CO; Evans R; Beall D; Fong M
J Immunol; 1992 Jun; 148(11):3674-8. PubMed ID: 1534101
[TBL] [Abstract][Full Text] [Related]
60. Expressing human interleukin-15 from oncolytic vesicular stomatitis virus improves survival in a murine metastatic colon adenocarcinoma model through the enhancement of anti-tumor immunity.
Stephenson KB; Barra NG; Davies E; Ashkar AA; Lichty BD
Cancer Gene Ther; 2012 Apr; 19(4):238-46. PubMed ID: 22158521
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
